Mariner’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,968
Closed -$251K 3047
2023
Q2
$251K Sell
5,968
-785
-12% -$31.7K ﹤0.01% 2264
2023
Q1
$240K Sell
6,753
-2,432
-26% -$88.3K ﹤0.01% 2251
2022
Q4
$337K Buy
9,185
+1,463
+19% +$57.8K ﹤0.01% 1936
2022
Q3
$364K Buy
+7,722
New +$499K ﹤0.01% 1640

Other funds holding SYNH

Mariner's SYNH Position: Q3 2023 in Review

Mariner sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 5,968 shares — an estimated $251K sold.

Mariner first reported a position in SYNH in Q3 2022 and held it in 4 quarters. The position peaked at $364K in Q3 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Mariner reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Mariner sold 5,968 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $251K.
  • Mariner first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2022 and held it in 4 quarters.
  • Mariner's Syneos Health, Inc. Class A Common Stock position peaked at $364K in Q3 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Mariner's 13F filing for Q3 2023, filed 13 Nov 2023.